• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类和超广谱β-内酰胺酶感染的临床分布及耐药趋势的长期特征:2014 - 2022年

Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Infections: 2014-2022.

作者信息

Wang Na, Zhan Minghua, Wang Teng, Liu Jinlu, Li Caiqing, Li Baoliang, Han Xuying, Li Huiying, Liu Shuting, Cao Jing, Zhong Xinran, Lei Chunmei, Zhang Wei, Zhang Zhihua

机构信息

Microbiology Department, The First Affiliated Hospital of Hebei North University, Zhangjiakou, People's Republic of China.

Clinical Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou, People's Republic of China.

出版信息

Infect Drug Resist. 2023 Mar 4;16:1279-1295. doi: 10.2147/IDR.S401807. eCollection 2023.

DOI:10.2147/IDR.S401807
PMID:36910515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9994629/
Abstract

PURPOSE

Through long-term and large sample size statistical analysis, we revealed the pattern of (KP) infection and drug resistance and provided epidemiological data for the treatment and prevention and control of multidrug-resistant bacterial infection in our hospital.

PATIENTS AND METHODS

Strains were identified using the BD Phoenix100 system, minimal inhibitory concentration of antibiotics were determined by the broth method, and data were statistically analyzed using WHONET 5.6 and SPSS27.0.

RESULTS

The isolation rate of KP from Enterobacteriaceae (26.2%, 4547/17358) in our hospital showed an increasing annual trend, ranking second only to . Carbapenem-resistant KP (CRKP) accounted for the highest proportion of carbapenem-resistant Enterobacteriaceae (72.2%, 431/597), showing an upward trend. Infected patients had a male-to-female ratio of approximately 2:1 and were mainly >60 years of age (66.2%), with intensive care units being the most commonly distributed department. Sputum was the most common specimen type (74.0%). Compared with spring and summer, autumn and winter were the main epidemic seasons for KP and extended-spectrum β-lactamase KP (ESBL-KP). The resistance rate of KP to common antibiotics was low, but all showed an increasing trend each year. ESBL-KP was >90% resistant to piperacillin, amoxicillin/clavulanic acid, and cefotaxime and less resistant to other common antibiotics, but showed an increasing trend in resistance to most antibiotics. CRKP resistance to common antibiotics was high, with resistance rates >90%, excluding amikacin (64.1%), gentamicin (87.4%), cotrimoxazole (44.3%), chloramphenicol (13.6%), and tetracycline (30.5%).

CONCLUSION

KP in our hospital mainly caused pulmonary infection in older men, which occurred frequently in autumn and winter, and the isolation and drug resistance rates showed an increasing trend. Age over 70 years, admission to intensive care unit, and urinary tract infection were found to be the risk factors for CRKP and ESBL-KP-resistance.

摘要

目的

通过长期大样本量统计分析,揭示肺炎克雷伯菌(KP)感染及耐药模式,为我院多重耐药菌感染的治疗及防控提供流行病学资料。

患者与方法

采用BD Phoenix100系统鉴定菌株,肉汤法测定抗生素最低抑菌浓度,应用WHONET 5.6和SPSS27.0对数据进行统计分析。

结果

我院肺炎克雷伯菌在肠杆菌科中的分离率(26.2%,4547/17358)呈逐年上升趋势,仅次于……。耐碳青霉烯类肺炎克雷伯菌(CRKP)在耐碳青霉烯类肠杆菌科细菌中占比最高(72.2%,431/597),呈上升趋势。感染患者男女比例约为2:1,主要为60岁以上人群(66.2%),重症监护病房为最常见分布科室。痰液是最常见的标本类型(74.0%)。与春夏季相比,秋冬季是肺炎克雷伯菌及产超广谱β-内酰胺酶肺炎克雷伯菌(ESBL-KP)的主要流行季节。肺炎克雷伯菌对常用抗生素的耐药率较低,但均呈逐年上升趋势。ESBL-KP对哌拉西林、阿莫西林/克拉维酸和头孢噻肟的耐药率>90%,对其他常用抗生素耐药率较低,但对大多数抗生素的耐药率呈上升趋势。CRKP对常用抗生素耐药率较高,耐药率>90%,但对阿米卡星(64.1%)、庆大霉素(87.4%)、复方磺胺甲恶唑(44.3%)、氯霉素(13.6%)和四环素(30.5%)除外。

结论

我院肺炎克雷伯菌主要引起老年男性肺部感染,秋冬季节高发,分离率及耐药率呈上升趋势。70岁以上、入住重症监护病房及尿路感染是CRKP及ESBL-KP耐药的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/eae366533c86/IDR-16-1279-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/e86e3b1be3f9/IDR-16-1279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/2f4e36c5b078/IDR-16-1279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/41687c10a908/IDR-16-1279-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/7dfe68ca4a58/IDR-16-1279-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/94cbd1bf3f74/IDR-16-1279-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/74026483ed0c/IDR-16-1279-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/45aa8100c274/IDR-16-1279-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/02ef91b2bdaa/IDR-16-1279-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/eae366533c86/IDR-16-1279-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/e86e3b1be3f9/IDR-16-1279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/2f4e36c5b078/IDR-16-1279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/41687c10a908/IDR-16-1279-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/7dfe68ca4a58/IDR-16-1279-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/94cbd1bf3f74/IDR-16-1279-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/74026483ed0c/IDR-16-1279-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/45aa8100c274/IDR-16-1279-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/02ef91b2bdaa/IDR-16-1279-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/9994629/eae366533c86/IDR-16-1279-g0009.jpg

相似文献

1
Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Infections: 2014-2022.耐碳青霉烯类和超广谱β-内酰胺酶感染的临床分布及耐药趋势的长期特征:2014 - 2022年
Infect Drug Resist. 2023 Mar 4;16:1279-1295. doi: 10.2147/IDR.S401807. eCollection 2023.
2
Epidemiologic analysis and control strategy of infection in intensive care units in a teaching hospital of People's Republic of China.中华人民共和国某教学医院重症监护病房感染的流行病学分析与防控策略
Infect Drug Resist. 2019 Feb 12;12:391-398. doi: 10.2147/IDR.S189154. eCollection 2019.
3
Antimicrobial Susceptibility Differences Between Carbapenem-Resistant KPC-2-Producing and NDM-1-Producing in a Teaching Hospital in Northeast China.中国东北地区一家教学医院中产碳青霉烯酶KPC-2和产NDM-1菌株的抗菌药物敏感性差异
Microb Drug Resist. 2020 Feb;26(2):94-99. doi: 10.1089/mdr.2018.0398. Epub 2019 Aug 21.
4
Phenotypic and Molecular Characterization of Antimicrobial Resistance in Klebsiella spp. Isolates from Companion Animals in Japan: Clonal Dissemination of Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.日本伴侣动物分离的克雷伯菌属菌株耐药性的表型和分子特征:产超广谱β-内酰胺酶的多重耐药肺炎克雷伯菌的克隆传播
Front Microbiol. 2016 Jun 29;7:1021. doi: 10.3389/fmicb.2016.01021. eCollection 2016.
5
Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens.儿童下呼吸道感染相关细菌病原体的分布及耐药性以及新型冠状病毒肺炎对病原体分布的影响
Can J Infect Dis Med Microbiol. 2022 Mar 29;2022:1181283. doi: 10.1155/2022/1181283. eCollection 2022.
6
[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].人工气道患者耐碳青霉烯类肺炎克雷伯菌感染相关因素分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1324-1330. doi: 10.3760/cma.j.cn121430-20200601-00431.
7
Risk Factors for Carbapenem-resistant Infection and Mortality of Infection.耐碳青霉烯类 感染的危险因素和 感染的死亡率。
Chin Med J (Engl). 2018 Jan 5;131(1):56-62. doi: 10.4103/0366-6999.221267.
8
Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.台湾一家教学医院中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌对磷霉素和呋喃妥因的药敏性。
J Microbiol Immunol Infect. 2011 Oct;44(5):364-8. doi: 10.1016/j.jmii.2010.08.012. Epub 2011 Jan 20.
9
Epidemiology of bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality.一家教学医院血流感染的流行病学:与碳青霉烯耐药性及患者死亡率相关的因素
Antimicrob Resist Infect Control. 2016 Nov 17;5:48. doi: 10.1186/s13756-016-0145-0. eCollection 2016.
10
Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.在尼泊尔加德满都一家三级护理医院中,从不同临床样本分离出的大肠埃希菌和肺炎克雷伯菌中产超广谱β-内酰胺酶和金属β-内酰胺酶的情况。
Ann Clin Microbiol Antimicrob. 2017 Sep 19;16(1):62. doi: 10.1186/s12941-017-0236-7.

引用本文的文献

1
Multidrug-resistant coinfection with multiple microbes: a retrospective study on its risk factors and clinical outcomes.多重微生物的多重耐药合并感染:关于其危险因素和临床结局的回顾性研究。
mSystems. 2025 Jul 10:e0175724. doi: 10.1128/msystems.01757-24.
2
Fundamental changes in the antimicrobial resistance profile of Klebsiella quasipneumoniae ATCC 700603 in response to meropenem stress.肺炎克雷伯菌ATCC 700603对美罗培南应激反应的抗菌药物耐药谱的根本变化。
BMC Microbiol. 2025 Jun 26;25(1):369. doi: 10.1186/s12866-025-04100-6.
3
Clinical characteristics, risk factors and prognosis of infection in patients with different states of immune function: a retrospective study.

本文引用的文献

1
Molecular Detection of Mutation in Clinical Strains of ..临床菌株中突变的分子检测
Iran J Public Health. 2022 Oct;51(10):2334-2339. doi: 10.18502/ijph.v51i10.10992.
2
Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria.双碳青霉烯类联合用药对耐碳青霉烯革兰氏阴性菌的有效性。
Saudi Pharm J. 2022 Jun;30(6):849-855. doi: 10.1016/j.jsps.2022.03.007. Epub 2022 Mar 14.
3
The changing face of Klebsiella pneumoniae carbapenemase: in-vivo mutation in patient with chest infection.
不同免疫功能状态患者感染的临床特征、危险因素及预后:一项回顾性研究
Front Cell Infect Microbiol. 2025 May 30;15:1539554. doi: 10.3389/fcimb.2025.1539554. eCollection 2025.
4
Prevalence and molecular insights into carbapenem resistance: a 2-year retrospective analysis of superbugs in South India.碳青霉烯类耐药的流行情况及分子机制洞察:对印度南部超级细菌的两年回顾性分析
Front Med (Lausanne). 2025 May 30;12:1571231. doi: 10.3389/fmed.2025.1571231. eCollection 2025.
5
Chlorhexidine and benzalkonium chloride: promising adjuncts in combating multidrug resistant Klebsiella pneumoniae in healthcare settings.洗必泰和苯扎氯铵:在医疗机构对抗多重耐药肺炎克雷伯菌方面颇具前景的辅助药物。
BMC Infect Dis. 2025 May 7;25(1):670. doi: 10.1186/s12879-025-10980-w.
6
Impact of nitric oxide donors on capsule, biofilm and resistance profiles of Klebsiella pneumoniae.一氧化氮供体对肺炎克雷伯菌囊泡、生物膜和耐药谱的影响。
Int J Antimicrob Agents. 2024 Nov;64(5):107339. doi: 10.1016/j.ijantimicag.2024.107339. Epub 2024 Sep 18.
7
Phenotypic antibiotic susceptibility profile of clinical Enterobacteriaceae isolates from Kaduna State, northwest Nigeria.尼日利亚西北部卡杜纳州临床肠杆菌科分离株的表型抗生素敏感性概况
Access Microbiol. 2024 Jun 20;6(6). doi: 10.1099/acmi.0.000747.v5. eCollection 2024.
8
Evolution of Antimicrobial Resistance in over 3 Years (2019-2021) in a Tertiary Hospital in Bucharest, Romania.罗马尼亚布加勒斯特一家三级医院3年(2019 - 2021年)内抗菌药物耐药性的演变
Antibiotics (Basel). 2024 May 10;13(5):431. doi: 10.3390/antibiotics13050431.
9
Infection with the multidrug-resistant Klebsiella pneumoniae New Delhi metallo-B-lactamase strain in patients with COVID-19:感染与 COVID-19 患者多药耐药肺炎克雷伯菌新德里金属β-内酰胺酶株:
Front Cell Infect Microbiol. 2024 Apr 16;14:1297312. doi: 10.3389/fcimb.2024.1297312. eCollection 2024.
10
The Impact of ESBLs-Positive 's Resistance to Cefepime and Its Guidance for Clinical Treatment.产超广谱β-内酰胺酶(ESBLs)菌对头孢吡肟的耐药性影响及其临床治疗指导
Infect Drug Resist. 2023 Sep 27;16:6395-6404. doi: 10.2147/IDR.S427836. eCollection 2023.
肺炎克雷伯菌碳青霉烯酶的变化面貌:胸部感染患者的体内突变
Lancet. 2022 Jun 11;399(10342):2226. doi: 10.1016/S0140-6736(22)01011-X.
4
Prevalence of Carbapenem-Resistant Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution.中国北方某省耐碳青霉烯类感染的患病率:临床特征、耐药性及地理分布
Infect Drug Resist. 2022 Feb 22;15:569-579. doi: 10.2147/IDR.S347343. eCollection 2022.
5
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
6
Genomic epidemiology study of Klebsiella pneumoniae causing bloodstream infections in China.中国肺炎克雷伯菌血流感染的基因组流行病学研究
Clin Transl Med. 2021 Nov;11(11):e624. doi: 10.1002/ctm2.624.
7
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of .临床分离株 的毒力因子、抗生素耐药模式和分子分型。
Expert Rev Anti Infect Ther. 2022 Mar;20(3):463-472. doi: 10.1080/14787210.2022.1990040. Epub 2021 Oct 28.
8
New Trimethoprim-Like Molecules: Bacteriological Evaluation and Insights into Their Action.新型类甲氧苄啶分子:细菌学评估及其作用机制洞察
Antibiotics (Basel). 2021 Jun 12;10(6):709. doi: 10.3390/antibiotics10060709.
9
Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: a cross-sectional study of risk factors and bacterial genomic diversity.普通成年人群中肺炎克雷伯菌的胃肠道携带情况:一项横断面研究,分析其危险因素和细菌基因组多样性。
Gut Microbes. 2021 Jan-Dec;13(1):1939599. doi: 10.1080/19490976.2021.1939599.
10
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.优化携带 AME 基因 aac(6')-Ib 的产 KPC 肺炎克雷伯菌中氨基糖苷类药物的选择。
J Antimicrob Chemother. 2021 Feb 11;76(3):671-679. doi: 10.1093/jac/dkaa480.